FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff
No additional hiring is expected as US agency announces formal plan to return orphan review times to the original 90-day goal.
No additional hiring is expected as US agency announces formal plan to return orphan review times to the original 90-day goal.